CompletedPhase 3NCT00161876
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years
Studying Encephalitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pfizer
- Principal Investigator
- Jerzy Romaszko, MDPANTAMED sp. z o o.
- Intervention
- Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)(biological)
- Enrollment
- 3973 enrolled
- Eligibility
- 16-66 years · All sexes
- Timeline
- 2002 – 2002
Study locations (8)
- Zespol Opieki Zdrowotnej w Debicy, Dębica, Poland
- Wojewodzki Szpital Dzieciecy Oddzial Obserwacyjno - Zakazny A, Kielce, Poland
- "Atopia" Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego, Krakow, Poland
- Przedsiebiorstwo Uslug Medycznych "Centrum Medyczne Nowa Huta", Krakow, Poland
- Szpital Jana Pawla II Oddzial Neuroinfekcji, Krakow, Poland
- Samodzielny Publiczny Zaklad Opieki Zdrowotnej Oddzial Pediatryczny, Lubartów, Poland
- PANTAMED sp. z o.o., Olsztyn, Poland
- Oddzial Chorób Zakaznych Specjalistyczny Szpital im. E. Szczeklika, Tarnów, Poland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00161876 on ClinicalTrials.govOther trials for Encephalitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07332234Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral PathologiesSpitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"
- ACTIVE NOT RECRUITINGNCT06820060Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel PlusQIAGEN Gaithersburg, Inc
- ACTIVE NOT RECRUITINGPHASE2NCT06899802A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV VaccineBavarian Nordic
- RECRUITINGPHASE1, PHASE2NCT06680128A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsSK Bioscience Co., Ltd.
- RECRUITINGNCT06368648CoMind Early Feasibility StudyCoMind Technologies Limited
- ACTIVE NOT RECRUITINGPHASE4NCT06678373Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence AreasLiaoning Chengda Biotechnology CO., LTD
- RECRUITINGPHASE2NCT06510426Early Interferon-beta Treatment for West-Nile Virus InfectionTel-Aviv Sourasky Medical Center
- RECRUITINGNCT07191223Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in FranceUniversity Hospital, Strasbourg, France